Product Information

LIRAGLUTIDE 5-PAK 18 MG/3 ML is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $63.1806 per ML under NDC 00480725046. Its NADAC has been published 28 times since Dec 17, 2025.

LIRAGLUTIDE 5-PAK 18 MG/3 ML

Liraglutide
$63.1806per ML

Strength

6 mg/mL

NDC

00480725046

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

6/17/2026

Active Ingredients

LIRAGLUTIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA214568

On Market Since

8/28/2025

Pharmacological Classes

GLP-1 Receptor Agonist
Glucagon-Like Peptide 1
Glucagon-like Peptide-1 (GLP-1) Agonists

Price Statistics

The NADAC for LIRAGLUTIDE 5-PAK 18 MG/3 ML has been published 28 times since Dec 17, 2025, and over the history we have for it it has declined 12.0%. The table below summarizes its recorded NADAC range and movement.

Current price$63.1806 per ML
All-time high$73.7391 (Feb 11, 2026)
All-time low$63.1806 (Jun 17, 2026)
52-week high$73.7391
52-week low$63.1806
Median price$71.4433
Average price$70.9668
Largest weekly change-11.9% (Jun 17, 2026)
Weeks tracked28
Tracking sinceDec 17, 2025

Price History

1W

0.0%

1M

-11.9%

3M

-10.6%

6M

-12.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

-12.0%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 47% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 47%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of LIRAGLUTIDE 5-PAK 18 MG/3 ML?

The current National Average Drug Acquisition Cost (NADAC) for LIRAGLUTIDE 5-PAK 18 MG/3 ML, manufactured by Teva Pharmaceuticals USA Inc., is $63.1806 per ML (NDC 00480725046), effective Jun 24, 2026.

How has the price of LIRAGLUTIDE 5-PAK 18 MG/3 ML changed over time?

Over the history we have for it, the NADAC for LIRAGLUTIDE 5-PAK 18 MG/3 ML has declined 12.0%. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.

What are the highest and lowest recorded NADAC prices for LIRAGLUTIDE 5-PAK 18 MG/3 ML?

Since Dec 17, 2025, the NADAC for LIRAGLUTIDE 5-PAK 18 MG/3 ML has ranged from a low of $63.1806 (Jun 17, 2026) to a high of $73.7391 (Feb 11, 2026), with a median of $71.4433 per ML.

Are there cheaper alternatives to LIRAGLUTIDE 5-PAK 18 MG/3 ML?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, LIRAGLUTIDE 3-PAK 18 MG/3 ML, is $33.4153 per ML — about 47% below LIRAGLUTIDE 5-PAK 18 MG/3 ML.

Who manufactures LIRAGLUTIDE 5-PAK 18 MG/3 ML?

LIRAGLUTIDE 5-PAK 18 MG/3 ML (NDC 00480725046) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.